> These are changes he hasn’t noticed in patients who have lost significant weight in other ways—like through diet or gastric bypass surgery—which makes him think it’s unique to GLP-1 usage.
> (“We see a similar pattern in other causes of rapid weight loss, including gastric bypass surgery, he says.) In some cases, the loss of subcutaneous fat is significant enough that it impacts a patients’ ability to get injectables ..
So which is it?
My takeaway was that losing weight fast == problematic.
The article dials up the FUD factor to the max, which makes me question the quality of reporting and any intent to accurately inform vs. just get clicks.
This is missing one option. The source - plastic surgeons - may be people that profit from liposuction treatment. To keep patients they might not want people to use ozempic, or at least get people to notice changes in the face faster and get a facelift.